Pearl River Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-7,671
| Closed | -$315K | – | 297 |
|
2024
Q2 | $315K | Buy |
+7,671
| New | +$315K | 0.05% | 353 |
|
2021
Q2 | – | Sell |
-2,422
| Closed | -$276K | – | 546 |
|
2021
Q1 | $276K | Sell |
2,422
-922
| -28% | -$105K | 0.09% | 306 |
|
2020
Q4 | $463K | Sell |
3,344
-2,488
| -43% | -$344K | 0.17% | 195 |
|
2020
Q3 | $479K | Buy |
+5,832
| New | +$479K | 0.2% | 173 |
|
2020
Q2 | – | Sell |
-888
| Closed | -$39K | – | 521 |
|
2020
Q1 | $39K | Buy |
+888
| New | +$39K | 0.08% | 268 |
|
2019
Q1 | – | Sell |
-319
| Closed | -$14K | – | 696 |
|
2018
Q4 | $14K | Buy |
+319
| New | +$14K | 0.06% | 424 |
|